SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2,764.09 |
| Enterprise Value ($M) | 2,645.77 |
| Book Value ($M) | 379.91 |
| Book Value / Share | 6.73 |
| Price / Book | 7.28 |
| NCAV ($M) | 376.92 |
| NCAV / Share | 6.68 |
| Price / NCAV | 7.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.22 |
| Return on Assets (ROA) | -0.59 |
| Return on Equity (ROE) | -0.64 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.38 |
| Current Ratio | 19.38 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 398.41 |
| Assets | 401.40 |
| Liabilities | 21.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -93.00 |
| Net Income | -83.98 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -74.76 |
| Cash from Investing | -273.91 |
| Cash from Financing | 315.39 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Fairmount Funds Management LLC | 9.99 | -11.85 | |
| 13G/A | Deep Track Capital, LP | 6.25 | -23.15 | |
| 13G | Ra Capital Management, L.p. | 5.30 | ||
| 13G/A | Fmr Llc | 13.50 | 12.84 | |
| 13G | Access Industries Management, Llc | 5.22 | ||
| 13D | Venrock Healthcare Capital Partners III, L.P. | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark one) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 74,613 | 308,972 | 24.15 | |
| 53,862 | 263,408 | 20.45 | |
| 56,582 | 170,938 | 33.10 | |
| 61,361 | 94,876 | 64.67 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALPN – Alpine Immune Sciences, Inc. | ALT – Altimmune, Inc. |
| ANIP – ANI Pharmaceuticals, Inc. | APLT – Applied Therapeutics, Inc. |
| AQST – Aquestive Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io